|Numéro de publication||US20060030910 A1|
|Type de publication||Demande|
|Numéro de demande||US 11/044,997|
|Date de publication||9 févr. 2006|
|Date de dépôt||26 janv. 2005|
|Date de priorité||10 févr. 1993|
|Autre référence de publication||US6849083, US8506494, US20040034399, US20080114431|
|Numéro de publication||044997, 11044997, US 2006/0030910 A1, US 2006/030910 A1, US 20060030910 A1, US 20060030910A1, US 2006030910 A1, US 2006030910A1, US-A1-20060030910, US-A1-2006030910, US2006/0030910A1, US2006/030910A1, US20060030910 A1, US20060030910A1, US2006030910 A1, US2006030910A1|
|Cessionnaire d'origine||Radiant Medical, Inc.|
|Exporter la citation||BiBTeX, EndNote, RefMan|
|Citations de brevets (87), Référencé par (5), Classifications (20), Événements juridiques (5)|
|Liens externes: USPTO, Cession USPTO, Espacenet|
The following application is a continuation-in-part of U.S. Pat. No. 5,486,208, dated Jan. 23, 1996 which was a continuation of application Ser. No. 08/015,774 filed Feb. 10, 1993, now abandoned, the full disclosures of which is incorporated herein by reference.
1. Field of the Invention
The present invention relates generally to the selective modification and control of a patient's body temperature. More particularly, the present invention provides methods and apparatus for treating hypothermia or hyperthermia by inserting a catheter into a blood vessel of the patient and selectively transferring heat to or from blood flowing through the vessel.
2. Description of the Background Art
Under ordinary circumstances the thermoregulatory system of the human body maintains a near constant temperature of about 37° C. (98.6° F.). Heat lost to the environment is precisely balanced by heat produced within the body.
Hypothermia is a condition of abnormally low body temperature. Hypothermia can be clinically defined as a core body temperature of 35° C. or less. Hypothermia is sometimes characterized further according to its severity. A body core temperature in the range from 32° C. to 35° C. is described as “mild” hypothermia, 30° C. to 32° C. is called “moderate,” 24° C. to 30° C. is described as “severe,” and a body temperature less than 24° C. constitutes “profound” hypothermia. Although the above ranges provide a useful basis for discussion, they are not absolutes and definitions vary widely in the medical literature.
Accidental hypothermia results when heat loss to the environment exceeds the body's ability to produce heat internally. In many cases, thermoregulation and heat production are normal but the patient becomes hypothermic due to overwhelming environmental cold stress. This is a relatively common condition, often resulting from exposure to the elements. Hypothermia may also occur in patients exposed to mild cold stress whose thermoregulatory ability has been lessened due to injury or illness. For example, this type of hypothermia sometimes occurs in patients suffering from trauma or as a complication in patients undergoing surgery.
Hypothermia of either type is a dangerous condition which can have serious medical consequences. In particular, hypothermia interferes with the ability of the heart to pump blood. Hypothermia may be fatal for this reason alone. Additionally, low body temperature seriously interferes with the enzymatic reactions necessary for blood clotting. This sometimes results in bleeding that is very difficult to control, even when normal clotting factor levels are present. These effects and other adverse consequences of hypothermia lead to drastically increased mortality rates both among victims of trauma and in patients undergoing surgery.
Simple methods for treating hypothermia have been known since very early times. Such methods include wrapping the patient in blankets, administering warm fluids by mouth, and immersing the patient in a warm water bath. While these methods are very effective for mild hypothermia, more intrusive methods have been developed for treating severe and profound cases of hypothermia. In particular, methods have been devised to effect direct heating of a patient's blood. Most commonly, blood is withdrawn from patient's circulation, passed through external warming equipment, and reinfused back into the patient. Alternatively, the use of heated catheters has been proposed, where a catheter having a heating element near its distal end is inserted into the patient's vasculature and heat directly transferred into the patient's circulating blood.
While the direct heating of patient blood can be highly effective, even in treating severe and profound cases of hypothermia, it has been observed by the inventor herein that the excess transfer of heat can cause the patient's temperature to rise above normal body temperature, resulting in hyperthermia. Hyperthermia can occur, for example, when a hypothermic patient's metabolism begins to produce substantial amounts of heat at the same time heat is being transferred directly to the blood.
It would therefore be desirable to provide methods for treating hypothermia which further provide for treatment of accidental or incidental hyperthermia. In particular, it would be desirable to develop systems and methods for transferring heat to the blood where heat can be optionally removed if the patient blood or body temperature exceeds a target level. Such methods and devices will preferably employ a catheter for direct heat transfer into circulating blood, but could also be useful with methods where blood is heated externally from the patient's body. Such systems and methods should further be useful for the treatment of patients who are initially hyperthermic, where the methods and systems provide for initial cooling of the blood and optional heating of the blood should the patient blood or body temperature fall below a target temperature.
The present invention provides apparatus and methods for restoring normal body temperature in patients initially suffering from hypothermia or hyperthermia. The apparatus includes a catheter and a control unit which together permit selective heating and cooling of the patient's circulating blood. For hypothermic patients, the method will provide for initially heating the blood until a target blood or body temperature has been restored. Heating will be stopped after reaching the target temperature. Even after the heating has been stopped, however, the patient's blood and/or body temperature will continue to be monitored to assure that the blood or body temperature does not overshoot the target. As discussed above, an initially hypothermic patient can become hyperthermic if the total amount of heat experienced from both patient metabolism and external heating exceeds that necessary to restore normal body temperature. In the case of patients entering hyperthermia, the method of the present invention provides for cooling the patient's blood, usually using the same intravascular catheter or other apparatus which has been used for heating.
In the case of initially hyperthermic patients, the method of the present invention relies on cooling the patient's blood in order to reduce the blood and body temperature. Cooling will stop after a target temperature has been reached. The patient's blood and/or body temperature will continue to be monitored, however, and should the patient enter hypothermia, normal body temperature can then be restored by introducing an appropriate amount of heat to the circulating blood.
According to a first aspect of the present invention, a system for restoring normal body temperature to a patient comprises an intravascular catheter having at least one heat transfer surface, a temperature sensor, and a control unit connectable to the temperature sensor and the catheter. The control unit selectively transfers heat to or from the at least one heat transfer surface in order to achieve a desired target blood or body temperature. The intravascular catheter may comprise a single heat transfer surface for both heat generating and heat absorption, but will usually comprise both a heat-generating surface and a separate heat-absorbing surface. The heat-generating surface will typically comprise a resistance heater, such as a wire coil, and the heat-absorbing surface will typically comprise a metal foil wrapped around the catheter, typically having an exposed area of at least about 2 cm2. In such cases, the control unit may comprise an electrical current source connectable to the resistance heater and a thermal electric cooler connectable to the metal foil. In an alternative construction, the catheter may include at least one flow lumen which permits flow of a heat exchange medium within the catheter past the heat transfer surface. The control unit will then include a heater, a cooler, and a controller for selectively activating the heater or cooler to transfer heat to the heat exchange medium in order to restore normal body temperature to the patient. The heater may be an electrical resistance heater and the cooler may be a thermoelectric cooler.
The temperature sensor will typically be on the catheter and measure the blood temperature. Alternatively or additionally, temperature sensor(s) may be separately attachable to the patient to measure body temperature.
In a second aspect of the present invention, a catheter for restoring normal body temperature to a patient by selectively transferring heat to or from a patient's blood flow comprises a catheter body having a proximal end and a distal end. The distal end is insertable into a blood vessel, and the heat-generating heat exchange surface and a heat-absorbing heat exchange surface are both disposed near the distal end of the catheter body. Typically, the catheter body will have a length in the range from about 15 cm to 50 cm and a diameter in the range from 1 mm to 5 mm. The heat-generating heat transfer surface will usually comprise an electrical resistance heater, and the catheter will further comprise a connector which connects the resistance heater to an external current source. The heat-absorbing heat transfer surface will typically comprise a metal foil wrapped around the catheter body, and a heat-conductive element will extend through the catheter body to near the proximal end to permit the heat-absorbing foil to be connected to a cooler in a separate control unit. The metal foil heat-absorbing surface will typically have an area of at least 2 cm2, usually being from 4 cm2 to 80 cm2. The heat-conductive element could be either a continuation of the metal foil surface (preferably being insulated in portions which will not lie within the blood circulation), or alternatively could be a metal core composed of a heat-conductive material.
According to the method of the present invention, normal body temperatures are restored to a patient by selectively introducing heat to the patient's blood flow for hypothermic patients or removing heat from the blood flow for hyperthermic patients. Usually, the heat will be introduced or removed via an intravascular catheter which is connected to an external control unit. Alternatively, the method of the present invention will also comprise the direct extracorporeal heating and cooling of the blood. A temperature characteristic of the patient is monitored, typically being blood temperature and/or body temperature. If the temperature characteristic indicates that initially hypothermic patients have or are about to become hyperthermic, then heat will be removed from the circulating blood to restore normal body temperature. Similarly, if the monitored temperature characteristic indicates that initially hypothermic patients are about to become hyperthermic, then heat will be removed from the blood of those patients until normal body temperature has been restored.
The preferred intravascular catheters will be inserted into a blood vessel, usually being the femoral artery or vein, or the jugular artery or vein. The heat-introducing step comprises introducing heat at a rate between 10 W and 500 W, usually between 50 W and 250 W, while the heat removing step comprises removing heat at a rate from 1 W to 100 W. Preferably, the catheter and system described above will be employed.
For initially hypothermic patients, the temperature characteristic will usually be blood temperature, and the target blood temperature, i.e., temperature at which heating is stopped, will be 36.9° C. Should the blood temperature exceed 39° C., then cooling will commence. For initially hyperthermic patients, the preferred temperature characteristic will be blood temperature, and the target temperature at which cooling will be stopped will be about 36.9° C. Should the blood continue to cool, typically to a temperature of 36° C. or below, then blood heating will commence. Is should be appreciated, however, that these temperature targets are nominal objectives, and the methods of the present invention can be practiced with target temperatures which differ somewhat from those just set forth.
The present invention provides methods and apparatus for selectively modifying and controlling a patient's body temperature by warming or cooling the patient's blood, usually using an intravascular catheter in situ. According to the preferred method of the present invention, the catheter is inserted through a puncture or incision into a blood vessel in the patient's body. By warming or cooling a portion of the catheter, heat may be transferred to or from blood flowing within the vessel and the patient's body temperature may thereby be increased or decreased as desired. During the procedure, the patient's blood and/or body core temperature may be independently monitored and treatment may continue until the patient's blood and/or body core temperature approaches the desired level, usually the normal body temperature of about 37° C. Such methods will find use in treating undesirable conditions of hypothermia and hyperthermia and may also be used to induce an artificial condition of hypothermia when desired, e.g., to temporarily reduce a patient's need for oxygen. In such a case, the patient's temperature may be reduced several degrees Celsius below the normal body temperature.
In treating conditions of hypothermia and hyperthermia there is the possibility that the patient's core body temperature will “overshoot” the target normal body temperature. The body's metabolic response to the external heating or cooling being applied, as described above, can result in overcompensation of the initial condition. In particular, when heating the patient's body to treat hypothermia, the body's own heat generation arising from internal metabolic processes may raise the body temperature in an unpredictable manner, resulting in a body temperature that can rise well above normal body temperature. In such cases, the present invention provides for a reversal of the transfer of heat from or to the patient's blood. In the case of an uncontrolled temperature rise, the system of the present invention will be switched so that heat will be withdrawn from the circulating blood. Conversely, in the case of overcooling of the patient's body, the system will be switched so that heat will be introduced to the patient.
For example, the jugular vein may have a diameter of about 22 French, or a bit more than 7 millimeters (1 French=0.013 inches=0.33 mm). A catheter suitable for insertion into a vessel of this size can be made quite large relative to catheters intended for insertion into other regions of the vascular system. Atherectomy or balloon angioplasty catheters are sometimes used to clear blockages from the coronary artery and similar vessels. These catheters commonly have external diameters in the range between 2 and 8 French.
In contrast, it is anticipated that a catheter according to the present invention will typically have an external diameter of about 10 French or more, although this dimension may obviously be varied a great deal without departing from the basic principles of the claimed invention. It is desirable that the catheter be small enough so that the puncture site can be entered using the percutaneous Seldinger technique, a technique well known to medical practitioners. To avoid vessel trauma, the catheter will usually be less than 12 French in diameter upon insertion. Once in the vessel however, the distal or working end of the catheter can be expanded to any size so long as blood flow is not unduly impeded.
Additionally, the femoral artery and vein and the jugular vein are all relatively long and straight blood vessels. This will allow for the convenient insertion of a catheter having a temperature controlled region of considerable length. This is of course advantageous in that more heat may be transferred at a given temperature for a catheter of a given diameter if the length of the heat transfer region is increased.
Techniques for inserting catheters into the above mentioned blood vessels are well known among medical personnel. Although the method of the present invention will probably be most commonly employed in a hospital, the procedure need not be performed in an operating room. The apparatus and procedure are so simple that the catheter may be inserted and treatment may begin in some cases even in an ambulance or in the field.
The distal end 15 of the catheter may be heated or cooled as desired and held at a temperature either somewhat above or somewhat below the patient's body temperature. Blood flowing through the vessel will thereby be warmed or cooled. That blood will be circulated rapidly throughout the patient's circulatory system. The beneficial effect of warming or cooling the patient's blood in the vicinity of the catheter will thereby be spread very quickly throughout the entire body of the patient.
Electrical conduction leads 22 and 23 are connected to a resistance heating element 28, as depicted in
Temperature measurement lead 25 is connected to a temperature sensor 30. The temperature sensor facilitates the control of current flow through the heating coil. It is important to closely monitor the temperature of the distal end of the catheter and thus the flow of heat into the patient's blood. Care must be taken not to overheat the blood while still providing an adequate rate of heat transfer into the patient. The provision of a sensitive temperature sensor at the distal end of the catheter will help to achieve this goal.
In the embodiment depicted, heat transfer region 62 is in the form of a balloon 70. Use of a balloon will be advantageous in some embodiments to provide an increased surface area through which heat transfer may take place. Balloon inflation is maintained by a pressure difference in the fluid as it flows through in-flow lumen 60 and out-flow lumen 64. The balloon should be inflated to a diameter somewhat less than that of the inside diameter of the blood vessel so as not to unduly impede the flow of blood through the vessel.
Inclusion of a balloon on a catheter employing resistance heating allows for designs in which current is conducted through the fluid which fills the balloon. The catheter depicted in
A suitable fluid will allow current to flow between electrodes 86 and 88. Common saline solution, for example, contains dissolved ions which can serve as charge conductors. Electrical resistance within the fluid will cause the fluid to be heated, thus providing the desired warming of the catheter. The amount of warming will be dependant upon the voltage between the electrodes, the distance between them, and the resistivity of the fluid. The relation between these quantities is fairly simple; one skilled in the art will have no difficulty selecting appropriate values.
Resistance heating catheters like those depicted in
A catheter according to the present invention should be designed to optimize the rate of heat transfer between the catheter and blood flowing through the vessel. While a large surface area is desirable in order to maximize heat transfer, care must be taken so that the catheter does not unduly restrict blood flow through the vessel. Furthermore, the temperature of the catheter should be carefully controlled to prevent undesirable chemical changes within the blood. This is especially important when applying heat to the blood as blood is readily denatured by even moderately high temperatures. The exterior temperature of a catheter for warming blood should generally not exceed about 42° C.-43° C.
It is estimated that a catheter whose surface temperature is controlled between 37° C. and 42° C. will provide a body core warming rate of approximately one to two degrees Celsius per hour in a patient starting out with severe hypothermia. This estimate is highly dependant on a number of factors including the rate of blood flow through the vessel, the initial body temperature of the patient, the external surface area of the catheter through which heat is conducted, etc. The actual rate achieved may vary substantially from the above estimate.
The above estimate provides a starting point for a rough estimate as to the level of power transferred from the catheter to the patient's body and therefore of the size of the power supply required by the system. Regardless of the exact means of power transmission chosen, resistance heating coil, laser and diffusing tip, direct conduction or fluid circulation, an appropriate power supply will be required to provide heat to the system.
The sum of heat entering and leaving a patient's body can be written as:
ΔH=H c +H i −H e
where ΔH is the sum of all heat transferred, Hc is the heat transferred from the catheter to the patient, Hi the heat produced by the patient internally, and He the heat lost from the patient to the environment. If one assumes, as will ordinarily be the case in a healthy patient, that the body's internal thermoregulatory system will produce just enough heat to offset heat lost to the environment, then the equation is made simple:
The above equation can be written in terms of the change in the patient's internal body temperature over time as follows:
mc(ΔT/Δt)=(ΔH c /Δt)
where m is the body mass of the patient, c is the specific heat of the patient's body, (ΔT/Δt) is the time rate of change of the patient's internal body temperature, (ΔHc/Δt) is the time rate of heat delivery from the catheter to the patient.
If one assumes a patient having a body mass of 75 kilograms and a specific heat of 4186 joules/° C.-kg (assumes the specific heat of the human body to be the same as that of water, the actual value will be somewhat different), then a warming rate of 1° C. per hour (3600 seconds) will require the catheter to transfer heat to the patient at a rate of about 87 watts (1 watt=1 joule/sec).
However, as an estimate of the desirable size of a power supply to be used with a catheter of the present invention, this estimate is almost certainly too low. This is true for a number of reasons. First, it was assumed for the sake of convenience that the patient's internal system would produce an amount of heat equal to that lost to the environment. In a hypothermic patient this will obviously not be the case. Almost by definition, hypothermia occurs when a person's ability to produce heat internally is overwhelmed by heat lost to the environment. The catheter will have to make up the difference so the power level required will need to be greater for that reason alone.
Additionally, the above estimate does not allow for power losses between the power supply and whatever warming means is utilized. Such losses could include resistance losses in electrical transmission lines between the power supply and a resistance heating element, inherent inefficiencies and other losses in a system having a laser and a diffusing tip, heat losses along a thermally conductive shaft or fluid circulation lumen, and the like. Any such losses which do occur will need to be compensated for by additional power supply capacity.
Furthermore, it would be undesirable to limit the performance of a catheter according to the present invention by limiting the size of the power supply used. It would be preferable instead to use a power supply capable of providing power considerably in excess of that actually needed and then controlling the delivery of that power according to the measured temperature of the catheter itself. As mentioned previously, this can be readily accomplished by including a sensitive temperature sensor within the body of the catheter. Nevertheless, the above calculation can be used as a useful estimate of the likely lower bound for sizing a power supply for use in a catheter according to the present invention.
An alternative estimate can be made by comparing the likely performance of the various embodiments described herein with the power requirements for the external blood warming apparatus presently known. Such external warming apparatus generally requires a supply of power on the order of 1000-1500 watts and sometimes more. A device according to the present invention will most likely require considerably less power than that. First, the present invention requires no external pump to circulate the blood; this function is provided by the patient's own heart. Accordingly, no power is needed to drive such a pump. Secondly, the present invention is considerably less complicated than external blood warming systems. Known systems circulate the blood over a relatively lengthy path from the patient, through the warming element, and back into the patient. It is expected that more heat is lost over this lengthy path than will be lost in any device according to the present invention.
Thus, the power required by external blood circulation and warming systems of the type previously known can be used as a rough estimate of the likely upper limit for power required by a system according to the present invention. It is most likely that such a system will best be equipped with a power supply having a capacity somewhere between the two rough estimates described above. It is therefore contemplated that a suitable power supply will be capable of providing peak power somewhere in the range between 100 and 1500 watts, probably being in the range between 300 and 1000 watts. The ranges specified are an estimate of suitable peak power capability. The power supply will most commonly be thermostatically controlled in response to a temperature sensor in the body of the catheter. The actual effective power transmitted to the patient will therefore typically be much less than the peak power capacity of the system power supply.
With respect to a catheter for cooling, the temperature and power constraints are not as limiting as is the case in a catheter for warming blood. Care should merely be taken to avoid freezing the blood or inducing shock to the patient from too rapid cooling. Blood is essentially water containing a number of suspended and dissolved substances. As such, its freezing point is somewhat below 0° C. However, a catheter adapted to cool blood in a hyperthermic patient or to induce an artificial hypothermia will usually not be operated at temperatures that low. It is presently contemplated that the external surface of such a catheter may be held in the range between about 20° C. and 24° C., although the actual temperature could vary between about 0° C. and the patient's current body temperature (somewhat in excess of 37° C.).
Various embodiments of apparatus suitable for practicing the methods of the present invention have been described. Other embodiments and modifications will occur to those skilled in the art. For example, various means for heat transfer, e.g., resistance, including radio frequency, heating; laser energy; pumped fluids; etc., may be combined with various means for increasing the effective heat transfer surface area, e.g., balloons, fins, ribs, etc., to optimize the function of a device according to the present invention. Also, a temperature sensor will typically be used although for ease of illustration such a sensor is not depicted in all of the embodiments described. Furthermore, although most of the figures depict embodiments in which only a limited portion of the catheter is temperature controlled, no reason exists to prevent warming or cooling substantially the whole length of the catheter.
Broadly stated, the present invention provides a method for modifying a patient's body temperature by controlling the temperature of a catheter inserted into a blood vessel of the patient. Although several illustrative examples of means for practicing the invention are described above, these examples are by no means exhaustive of all possible means for practicing the invention. The scope of the invention should therefore be determined with reference to the appended claims, along with the full range of equivalents to which those claims are entitled.
The present invention thus provides methods for both raising the body temperature of initially hypothermic patients and lowering the body temperature of patients who are initially hyperthermic or for whom the body temperature is to be lowered below normal for some other purpose. In all cases, it is possible that the target body temperature will be inadvertently exceeded due to an uncontrollable physiologic response of the patient, e.g., initially hypothermic patients may become hyperthermic and initially hyperthermic patients may become hypothermic. In such cases, the present invention specifically provides for reversing the heat transfer process so that patients passing into hyperthermia can be immediately cooled and patients passing into hypothermia can be immediately warmed. The control schemes for both warming initially hypothermic and cooling initially hyperthermic patients are set forth in
TABLE 1 CONDITION Hypothermia Hyperthermia INITIAL BODY Below 35° C. Above 38° C. TEMPERATURE TARGET BODY 36° C. 37° C. TEMPERATURE TARGET BLOOD 36.9° C. 36.9° C. TEMPERATURE OVERSHOOT 39° C. 36° C. TEMPERATURE
A preferred system for the selective warming and cooling of patients is illustrated in
The exemplary heat-absorbing surface will be a thermally conductive metal foil, typically composed of a biologically compatible thermally conductive metal, such as gold, silver, aluminum, or the like. Copper will also be useful, but will have to be treated or encapsulated in order to enhance biocompatibility. The foil will typically be thin in order to enhance flexibility of the catheter body, typically having a thickness in the range from 0.001 mm to 0.01 mm.
The heat-absorbing surface 108 will be conductively coupled to a cooler located externally of the catheter, typically in a control unit 120 as described below. In the illustrated embodiment, the surface 108 is coupled by a thermally conductive core member 110 composed of a flexible rod or wire formed from one of the thermally conductive metals described above. Alternatively, thermal coupling can be achieved by extending the surface 108 proximally so that the proximal end of the surface can be coupled to the cooler. In the latter case, it will be preferable that the proximal portions of the surface 108 be thermally insulated to prevent cooling outside of the blood circulation.
The system will further comprise a control unit 120 which typically provides both the heat-generator and the cooler for coupling to the catheter 100. The heat-generator will usually comprise a direct current source for coupling to the resistance heater on the catheter. Usually, the direct current source will be a commercially available, temperature-controlled DC power supply, typically operating at a voltage in the range from 10 VDC to 60 VDC and a current output in the range from 1 A to 2.5 A. Usually, the power supply will be controlled to maintain the surface temperature of the heating surface 106 in the range from 40° C. to 42° C. As discussed above, the surface temperature should not exceed 42° C. in order to prevent damage to blood components. Other desirable characteristics of the heat exchange surface are described above.
Optionally, the temperature of the heat exchange surface can also be controlled based on measured blood temperature and/or measured body temperature. Blood temperature can be measured by temperature sensors present on the catheter. For example, a temperature sensor 112 may be located on the catheter spaced-apart from the heat exchange surfaces 106 and 108. The temperature sensor 112 may be located either upstream or downstream from the heat exchange surfaces based on the direction of blood flow and depending on the manner in which the catheter is introduced to the patient. Optionally, a pair of temperature sensors could be provided, one disposed on each side of the heat exchange surfaces in order to measure both upstream and downstream blood temperatures. The catheter will also include a temperature sensor (not illustrated) coupled directly to the heat-generating surface 106 so that the temperature of the surface may be directly controlled. Other temperature sensors (not illustrated) may be provided for directly measuring the patient's core body temperature, with the core body temperatures being fed back into the control unit 120.
The cooler in control unit 120 may be any type of refrigeration unit capable of removing heat from the heat-absorbing surface 106 at a rate sufficient to cool the blood at a desired rate. Typically, the cooler will be rated at from 1 W to 100 W. Preferably, the cooler will be a thermoelectric cooler, such as those commercially available from Melcor Thermoelectrics, Trenton, N.J. 08648. The cooler will be directly coupled to the core element 110 so that direct heat conduction from the heat-absorbing surface 108 may be effected to the cooler in control unit 120. The temperature of the cooling surface 108 is less critical than that of the heating surface 106, but will usually be maintained in the range from 0° C. to 35° C. preferably being below 30° C. The temperature of the cooling surface may be directly controlled within this range, or alternatively the system may be designed so that the cooling temperature operates approximately within this range based on the total system characteristics.
The control unit 120 will further include one or more temperature controllers for controlling the temperature of the heat-generating surface 106 and the heat-absorbing surface 106 based on the blood temperature and/or the body temperature. At a minimum, the control unit 120 will provide for control of the temperature of the heat-generating surface 106 within the range set forth above, as well as for monitoring at least one of the patient blood temperature and patient body temperature in order to reverse the heating or cooling mode as discussed above. In the exemplary embodiment, as described in
It will be appreciated, for example, that the temperature control schemes of the present invention could be substantially more sophisticated. For example, the power input to warm the patient could be controlled based on proportional, derivative, or integral control schemes which will typically provide for a tapering of the heat transfer rate as the patient body temperature approaches the desired target level. Moreover, cascade control schemes based on both patient blood temperature and patient body temperature could be devised. Such control schemes, for example, could be adapted both for warming the patient and cooling the patient, with mathematical models of typical patient physiological characteristics being taken into account in preparing the control schemes. For the present, however, it is believed that a simple off-on control scheme with provision for reversing the heat transfer mode if the target temperature is exceeded by more than a safe amount will be sufficient.
|Brevet cité||Date de dépôt||Date de publication||Déposant||Titre|
|US1902016 *||12 févr. 1932||21 mars 1933||Copeman Lab Co||Refrigerating apparatus|
|US2308484 *||16 janv. 1939||19 janv. 1943||Davol Rubber Co||Catheter|
|US3369549 *||5 oct. 1965||20 févr. 1968||Thomas A. Armao||Capsule probe having thermoelectric heat exchange means therein|
|US3425419 *||2 juil. 1965||4 févr. 1969||Angelo Actis Dato||Method of lowering and raising the temperature of the human body|
|US3667476 *||27 avr. 1970||6 juin 1972||Bio Data Corp||Apparatus for monitoring body temperature and controlling a heating device to maintain a selected temperature|
|US3726283 *||7 oct. 1971||10 avr. 1973||Kendall & Co||Body-retained catheter|
|US3788328 *||29 avr. 1971||29 janv. 1974||Sherwood Medical Ind Inc||Cardiovascular catheter|
|US3901224 *||27 août 1973||26 août 1975||Investors In Ventures Inc||Thermal control of body functions|
|US3995617 *||31 mai 1972||7 déc. 1976||Watkins David H||Heart assist method and catheter|
|US4014317 *||18 févr. 1972||29 mars 1977||The United States Of America As Represented By The Department Of Health, Education And Welfare||Multipurpose cardiocirculatory assist cannula and methods of use thereof|
|US4038519 *||15 nov. 1974||26 juil. 1977||Rhone-Poulenc S.A.||Electrically heated flexible tube having temperature measuring probe|
|US4065264 *||10 mai 1976||27 déc. 1977||Shiley Laboratories, Inc.||Blood oxygenator with integral heat exchanger for regulating the temperature of blood in an extracorporeal circuit|
|US4111209 *||18 avr. 1977||5 sept. 1978||Datascope Corporation||Topical hypothermia apparatus and method for treating the human body and the like|
|US4181132 *||31 mai 1977||1 janv. 1980||Parks Leon C||Method and apparatus for effecting hyperthermic treatment|
|US4246932 *||18 oct. 1979||27 janv. 1981||Burron Medical, Inc.||Multiple additive valve assembly|
|US4298006 *||30 avr. 1980||3 nov. 1981||Research Against Cancer, Inc.||Systemic hyperthermia with improved temperature sensing apparatus and method|
|US4378797 *||14 avr. 1980||5 avr. 1983||Thomas Jefferson University||Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders|
|US4445500 *||30 sept. 1982||1 mai 1984||Thomas Jefferson University||Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders|
|US4445886 *||3 mars 1982||1 mai 1984||Thomas Jefferson University||Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders|
|US4470407 *||11 mars 1982||11 sept. 1984||Laserscope, Inc.||Endoscopic device|
|US4540402 *||20 avr. 1983||10 sept. 1985||Karl Aigner||Double perfusion catheter|
|US4661094 *||3 mai 1985||28 avr. 1987||Advanced Cardiovascular Systems||Perfusion catheter and method|
|US4662383 *||23 sept. 1983||5 mai 1987||Kureha Kagaku Kogyo Kabushiki Kaisha||Endotract antenna device for hyperthermia|
|US4672962 *||7 oct. 1985||16 juin 1987||Cordis Corporation||Plaque softening method|
|US4686085 *||23 févr. 1984||11 août 1987||Thomas Jefferson University||Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders|
|US4701166 *||2 oct. 1986||20 oct. 1987||Catheter Technology Corp.||Valved two-way catheter|
|US4705501 *||12 avr. 1982||10 nov. 1987||Regents Of The University Of Minnesota||Bi-directional, anti-reflux vascular access system|
|US4748979 *||13 avr. 1987||7 juin 1988||Cordis Corporation||Plaque resolving device|
|US4750493 *||28 févr. 1986||14 juin 1988||Brader Eric W||Method of preventing brain damage during cardiac arrest, CPR or severe shock|
|US4754752 *||27 juil. 1987||5 juil. 1988||Robert Ginsburg||Vascular catheter|
|US4769005 *||6 août 1987||6 sept. 1988||Robert Ginsburg||Selective catheter guide|
|US4804358 *||20 févr. 1986||14 févr. 1989||Medicorp Research Laboratories Corporation||Coronary perfusion pump|
|US4819655 *||4 août 1987||11 avr. 1989||Webler William E||Injectateless thermal cardiac output determination method and apparatus|
|US4840617 *||24 août 1988||20 juin 1989||Thomas Jefferson University||Cerebral and lumbar perfusion catheterization apparatus for use in treating hypoxic/ischemic neurologic tissue|
|US4846196 *||27 janv. 1987||11 juil. 1989||Wiksell Hans O T||Method and device for the hyperthermic treatment of tumors|
|US4857054 *||15 juil. 1988||15 août 1989||Eastman Kodak Company||Perfusion angioplasty catheter with pump assist|
|US4892095 *||17 mars 1987||9 janv. 1990||Nakhgevany Karim B||Endotracheal tube|
|US4892519 *||3 déc. 1987||9 janv. 1990||Advanced Cardiovascular Systems, Inc.||Steerable perfusion dilatation catheter|
|US4899741 *||11 avr. 1988||13 févr. 1990||Hgm Medical Laser Systems, Inc.||Laser heated probe and control system|
|US4909252 *||26 mai 1988||20 mars 1990||The Regents Of The Univ. Of California||Perfusion balloon catheter|
|US4920963 *||4 avr. 1988||1 mai 1990||Brader Eric W||Apparatus for preventing brain damage during cardiac arrest, CPR or severe shock|
|US4941475 *||7 août 1989||17 juil. 1990||Spectramed, Inc.||Thermodilution by heat exchange|
|US4976691 *||23 janv. 1989||11 déc. 1990||Harvinder Sahota||Topless catheters|
|US4995863 *||25 févr. 1988||26 févr. 1991||Catheter Technology Corporation||Catheter with slit valve|
|US5019075 *||31 juil. 1990||28 mai 1991||The Beth Israel Hospital||Method and apparatus for angioplasty|
|US5030210 *||8 févr. 1988||9 juil. 1991||Becton, Dickinson And Company||Catheter valve assembly|
|US5041089 *||8 sept. 1988||20 août 1991||Devices For Vascular Intervention, Inc.||Vascular dilation catheter construction|
|US5092841 *||17 mai 1990||3 mars 1992||Wayne State University||Method for treating an arterial wall injured during angioplasty|
|US5106360 *||11 févr. 1991||21 avr. 1992||Olympus Optical Co., Ltd.||Thermotherapeutic apparatus|
|US5112301 *||19 juin 1991||12 mai 1992||Strato Medical Corporation||Bidirectional check valve catheter|
|US5147355 *||23 sept. 1988||15 sept. 1992||Brigham And Womens Hospital||Cryoablation catheter and method of performing cryoablation|
|US5147385 *||25 oct. 1990||15 sept. 1992||Schneider (Europe) A.G.||Stent and catheter for the introduction of the stent|
|US5149321 *||10 oct. 1990||22 sept. 1992||Klatz Ronald M||Brain resuscitation device and method for performing the same|
|US5151100 *||3 juil. 1990||29 sept. 1992||Boston Scientific Corporation||Heating catheters|
|US5180364 *||3 juil. 1991||19 janv. 1993||Robert Ginsburg||Valved self-perfusing catheter guide|
|US5191883 *||22 mai 1990||9 mars 1993||Prutech Research And Development Partnership Ii||Device for heating tissue in a patient's body|
|US5196024 *||3 juil. 1990||23 mars 1993||Cedars-Sinai Medical Center||Balloon catheter with cutting edge|
|US5207640 *||15 juin 1992||4 mai 1993||Hattler Brack G||Method of anesthetizing a patient|
|US5211631 *||24 juil. 1991||18 mai 1993||Sheaff Charles M||Patient warming apparatus|
|US5230862 *||16 août 1991||27 juil. 1993||Cardiopulmonics, Inc.||Apparatus for extracorporeal blood oxygenation|
|US5234405 *||19 mai 1992||10 août 1993||Klatz Ronald M||Brain resuscitation device and method for performing the same|
|US5248312 *||1 juin 1992||28 sept. 1993||Sensor Electronics, Inc.||Liquid metal-filled balloon|
|US5250070 *||28 mai 1991||5 oct. 1993||Parodi Juan C||Less traumatic angioplasty balloon for arterial dilatation|
|US5257977 *||14 mars 1991||2 nov. 1993||Argomed Ltd.||Technique for localized thermal treatment of mammals|
|US5261399 *||22 mai 1991||16 nov. 1993||Klatz Ronald M||Brain cooling device and method for performing the same|
|US5269758 *||29 avr. 1992||14 déc. 1993||Taheri Syde A||Intravascular catheter and method for treatment of hypothermia|
|US5271743 *||5 mai 1992||21 déc. 1993||Hattler Brack G||System to optimize the transfer of gas through membranes|
|US5281213 *||16 avr. 1992||25 janv. 1994||Implemed, Inc.||Catheter for ice mapping and ablation|
|US5281215 *||15 juin 1992||25 janv. 1994||Implemed, Inc.||Cryogenic catheter|
|US5342301 *||13 août 1992||30 août 1994||Advanced Polymers Incorporated||Multi-lumen balloons and catheters made therewith|
|US5368591 *||23 nov. 1992||29 nov. 1994||Prutech Research And Development Partnership Ii||Heated balloon catheters|
|US5383856 *||19 mars 1993||24 janv. 1995||Bersin; Robert M.||Helical spiral balloon catheter|
|US5395314 *||1 juin 1993||7 mars 1995||Life Resuscitation Technologies, Inc.||Brain resuscitation and organ preservation device and method for performing the same|
|US5403281 *||25 sept. 1992||4 avr. 1995||Minnesota Mining And Manufacturing Company||Inline heat exchanger and cardioplegia system|
|US5423811 *||16 mars 1994||13 juin 1995||Cardiac Pathways Corporation||Method for RF ablation using cooled electrode|
|US5437673 *||4 févr. 1993||1 août 1995||Cryomedical Sciences, Inc.||Closed circulation tissue warming apparatus and method of using the same in prostate surgery|
|US5450561 *||29 juil. 1992||12 sept. 1995||Bull Hn Information Systems Inc.||Cache miss prediction method and apparatus for use with a paged main memory in a data processing system|
|US5474080 *||8 oct. 1993||12 déc. 1995||Abbott Laboratories||Method for monitoring cardiac output and protecting blood and tissue|
|US5486208 *||18 oct. 1994||23 janv. 1996||Ginsburg; Robert||Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification|
|US5545161 *||7 oct. 1994||13 août 1996||Cardiac Pathways Corporation||Catheter for RF ablation having cooled electrode with electrically insulated sleeve|
|US5624392 *||8 août 1994||29 avr. 1997||Saab; Mark A.||Heat transfer catheters and methods of making and using same|
|US5716386 *||8 févr. 1996||10 févr. 1998||The Ohio State University||Non-invasive aortic impingement and core and cerebral temperature manipulation|
|US5755690 *||21 oct. 1994||26 mai 1998||C. R. Bard||Multiple layer high strength balloon for dilatation catheter|
|US5837003 *||8 janv. 1996||17 nov. 1998||Radiant Medical, Inc.||Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification|
|US6436131 *||9 mars 2000||20 août 2002||Radiant Medical, Inc.||Heat exchange catheter having heat exchange surface formed of metal foil|
|US6620188 *||24 août 1998||16 sept. 2003||Radiant Medical, Inc.||Methods and apparatus for regional and whole body temperature modification|
|US6635076 *||4 déc. 2001||21 oct. 2003||Radiant Medical Inc.||System for controlling body temperature of a patient|
|Brevet citant||Date de dépôt||Date de publication||Déposant||Titre|
|US7857781||16 mai 2005||28 déc. 2010||Zoll Circulation, Inc.||Indwelling heat exchange catheter and method of using same|
|US8007525||6 juin 2007||30 août 2011||Zoll Circulation, Inc.||Method for endovascular management of body temperature|
|US8475509 *||9 août 2007||2 juil. 2013||Zoll Circulation, Inc.||Devices and methods for using endovascular cooling to treat septic shock and other disorders|
|US20050222653 *||16 mai 2005||6 oct. 2005||Alsius Corporation||Indwelling heat exchange catheter and method of using same|
|US20090043366 *||9 août 2007||12 févr. 2009||Radiant Medical, Inc.||Devices and methods for using endovascular cooling to treat septic shock and other disorders|
|Classification aux États-Unis||607/96, 607/113|
|Classification internationale||A61F2/958, A61F7/00, A61B18/00, A61M25/00, A61B17/22, A61B17/00, A61F7/12|
|Classification coopérative||A61M2025/1072, A61B2017/22051, A61B2018/00095, A61F7/123, A61M2025/1086, A61M25/1011, A61B18/00, A61B2017/00084, A61F2007/126, A61M25/00|
|7 mai 2007||AS||Assignment|
Owner name: BAY CITY CAPITAL FUND IV L.P., CALIFORNIA
Free format text: SECURITY AGREEMENT;ASSIGNOR:RADIANT MEDICAL, INC.;REEL/FRAME:019272/0773
Effective date: 20070430
|21 mai 2007||AS||Assignment|
Owner name: HORIZON TECHNOLOGY FUNDING COMPANY LLC,CONNECTICUT
Free format text: SECURITY AGREEMENT;ASSIGNOR:RADIANT MEDICAL, INC.;REEL/FRAME:019353/0087
Effective date: 20070430
|6 sept. 2007||AS||Assignment|
Owner name: BAY CITY CAPITAL FUND IV, L.P.,CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HORIZON TECHNOLOGY FUNDING COMPANY LLC;REEL/FRAME:019781/0792
Effective date: 20070906
|11 sept. 2007||AS||Assignment|
Owner name: BAY CITY CAPITAL FUND IV L.P.,CALIFORNIA
Free format text: SECURITY AGREEMENT;ASSIGNOR:RADIANT MEDICAL, INC.;REEL/FRAME:019812/0192
Effective date: 20070907
|21 mars 2008||AS||Assignment|
Owner name: ZOLL CIRCULATION, INC.,CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RADIANT MEDICAL, INC.;BAY CITY CAPITAL FUND IV, L.P.;REEL/FRAME:020684/0535
Effective date: 20070918